Status and phase
Conditions
Treatments
About
The study is being conducted to evaluate the effect of 3 dosing regimens of povorcitinib on pulmonary function
Enrollment
Sex
Ages
Volunteers
Inclusion criteria
Exclusion criteria
Primary purpose
Allocation
Interventional model
Masking
240 participants in 4 patient groups, including a placebo group
Loading...
Central trial contact
Incyte Corporation Call Center (ex-US); Incyte Corporation Call Center (US)
Data sourced from clinicaltrials.gov
Clinical trials
Research sites
Resources
Legal